Oric Pharmaceuticals, Inc.
ORIC· Nasdaq
Released Nov 12, 2024, after the close
10-Q filed Nov 12, 2024, 43 days after period end · 0000950170-24-125471
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$34.57M | -$25.48M | -$24.83M | -$18.43M |
| EPS Diluted | -$0.49 | -$0.44 | -$0.63 | -$0.47 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oric Pharmaceuticals, Inc. · CIK 1796280 · Engraved from SEC EDGAR